Patents by Inventor Gary W. Neal

Gary W. Neal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030212139
    Abstract: Topical application of a prostaglandin directly to the clitoris is effective for enhancing female sexual desire and responsiveness.
    Type: Application
    Filed: April 11, 2003
    Publication date: November 13, 2003
    Inventor: Gary W. Neal
  • Patent number: 6642274
    Abstract: The present invention relates to methods, compositions, devices and kits for the prevention and treatment of prostate disorders in mammals, including, but not limited to, benign prostatic hypertrophy, carcinoma of the prostate, prostadynia, prostatitis, and chronic prostatitis. The present invention provides methods for preventing and treating prostate disorders in mammals by administration of a therapeutic compound to mucosal membranes in the lower urinary tract of the mammal. The present invention also provides devices for administering a therapeutic compound to mucosal membranes in the lower urinary tract of the mammal.
    Type: Grant
    Filed: September 8, 2000
    Date of Patent: November 4, 2003
    Inventor: Gary W. Neal
  • Patent number: 6593369
    Abstract: Topical application of a prostaglandin directly to the clitoris is effective for enhancing female sexual desire and responsiveness.
    Type: Grant
    Filed: June 12, 2001
    Date of Patent: July 15, 2003
    Assignee: Vivus, Inc.
    Inventor: Gary W. Neal
  • Patent number: 6559184
    Abstract: Administration of a pharmaceutical composition in the form of a suppository comprising: (a) a prostaglandin vasodilator; (b) 15-hydroxyprostaglandindehydrogenase inhibitor: and (c) a base material that is solid at room temperature and releases components (a) and (b) when inserted in the urethra, is effective for the treatment of male erectile dysfunction.
    Type: Grant
    Filed: May 3, 2002
    Date of Patent: May 6, 2003
    Assignee: Androsolutions, Inc.
    Inventor: Gary W. Neal
  • Publication number: 20020128314
    Abstract: Administration of a pharmaceutical composition in the form of a suppository comprising:
    Type: Application
    Filed: May 3, 2002
    Publication date: September 12, 2002
    Inventor: Gary W. Neal
  • Patent number: 6414027
    Abstract: Administration of a pharmaceutical composition in the form of a suppository comprising: (a) a prostaglandin vasodilator; (b) 15-hydroxyprostaglandindehydrogenase inhibitor; and (c) a base material that is solid at room temperature and releases components (a) and (b) when inserted in the urethra, is effective for the treatment of male erectile dysfunction.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: July 2, 2002
    Assignee: Androsolutions, Inc.
    Inventor: Gary W. Neal
  • Patent number: 6410595
    Abstract: Administration of a pharmaceutical composition comprising: (a) a vasodilator; and (b) a 15-hydroxyprostaglandindehydrogenase inhibitor is effective for the treatment of male erectile dysfunction.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: June 25, 2002
    Assignee: Androsolutions, Inc.
    Inventor: Gary W. Neal
  • Publication number: 20020004529
    Abstract: Topical application of a prostaglandin directly to the clitoris is effective for enhancing female sexual desire and responsiveness.
    Type: Application
    Filed: October 20, 1997
    Publication date: January 10, 2002
    Inventor: GARY W. NEAL
  • Publication number: 20010044467
    Abstract: Topical application of a prostaglandin directly to the clitoris is effective for enhancing female sexual desire and responsiveness.
    Type: Application
    Filed: June 12, 2001
    Publication date: November 22, 2001
    Inventor: Gary W. Neal
  • Patent number: 6103765
    Abstract: Administration of a pharmaceutical composition comprising:(a) a vasodilator; and(b) a 15-hydroxyprostaglandindehydrogenase inhibitor is effective for the treatment of male erectile dysfunction.
    Type: Grant
    Filed: July 9, 1997
    Date of Patent: August 15, 2000
    Assignee: Androsolutions, Inc.
    Inventor: Gary W. Neal
  • Patent number: 4129832
    Abstract: A method of linearizing a voltage controlled oscillator wherein a control signal is shaped into ramp form by a memory and transmitted to the control input terminal of a voltage controlled oscillator to be linearized thereby causing the oscillator to generate a chirp. Nonlinearities in the chirp are detected and the memory reprogrammed so as to diminish detected nonlinearities by reshaping the ramp control signal.
    Type: Grant
    Filed: June 20, 1977
    Date of Patent: December 12, 1978
    Assignee: Harris Corporation
    Inventors: Gary W. Neal, Robert M. Montgomery